Baylor Genetics Backs Bill Expanding Medicaid Genomic Testing

Novartis Ianalumab Gains FDA Breakthrough Status for Sjögren’s Disease

First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study

Sila Realty Trust Acquires $43.1 Million Oklahoma Rehab Facility

Innovaccer and Hospitalogy Unveil Autonomous Healthcare Report

Genmab Reports Phase 3 Epcoritamab Results in DLBCL

Ntracts Elevates Executive Leadership to Support Next Phase of Healthcare Growth

Organon Gets FDA Approval to Extend NEXPLANON Implant Use

New Data Shows CAPLYTA Effective for Depression Remission

Apiject to Launch New U.S. Generic Injectable Facility

POMDOCTOR Expands Internet Hospital via Pharma Partnerships

Ouroboros Leads $60 Million Series A for Cytotheryx Liver Therapy